American BioSciences Rebuts Misleading Statements Made By Hungarian Competitor
Avemar(R) Inventor Endorses U.S. Introduction of New AveULTRA(TM)
12:25PM 11/20/09
By Rick Pearson, Senior Contributor
Buying Orient Paper in the $10 range means investors will likely be paying only three to five times next year's earnings.
11:31AM 11/20/09
05:16PM 11/19/09
American BioSciences Rebuts Misleading Statements Made By Hungarian Competitor
Avemar(R) Inventor Endorses U.S. Introduction of New AveULTRA(TM)
04:58PM 11/19/09
Europe Sees Upbeat Trading (RealMoney.com $)
The market is being pulled higher by the utilities, tech, oil and gas and basic materials sectors.
08:00AM 11/18/09
Targeting China's Green Industry
One Holding is targeting a number of green companies in China that are supported by government initiatives.
08:28AM 11/16/09
Digital River CEO Buys $5M Worth
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
11:49AM 11/13/09
Health Care Dispute: Costs Of Defensive Medicine
Health care dispute: Are "defensive medicine" and malpractice insurance driving costs?
01:21PM 11/04/09
3 Stocks With Unbelievable Expansion
HearUSA, China Clean Energy and Biostar Pharmaceuticals are three stocks with great growth prospects.
12:38PM 11/03/09
Bears have become extremely emboldened and are speaking of catastrophe. But other investors believe we simply are seeing a much-needed correction.
01:58PM 11/01/09
More PML Troubles for Biogen, Elan MS Drug: Biobuzz
European regulators update reports of serious brain infection tied to Tysabri.
10:25AM 10/29/09
Genta Melanoma Drug Study Disappoints: BioBuzz
Genasense year-end FDA filing now delayed.
07:57AM 10/29/09
Shares of China Sun Group appear to have plenty of room to rise, while those of A123 Systems have lost power.
10:07AM 10/28/09
Biotech Calendar: Key Upcoming Trials
Your quick-and-dirty guide to upcoming phase III clinical trials.
06:00AM 10/23/09
Seeking Clarity on Lotus Pharma
This company's shares should rise if it can do a better job of telling its story to investors.
02:04PM 10/22/09



Connect with TheStreet